Ashita Tolwani

Dr. Ashita Tolwani is Professor of Medicine at the University of Alabama at Birmingham (UAB) and holder of the Edwin A. Rutsky Endowed Chair in Nephrology. She holds a Master’s of Science in Clinical Epidemiology from the Harvard School of Public Health. She is Co-Director of Section of Critical Care Nephrology at UAB. Dr. Tolwani is the founder and Director of UAB Continuous Renal Replacement Therapy (CRRT) Academy where she oversees every aspect of the program. She also conducts CRRT training workshops internationally. Her dedication has resulted in her receiving numerous institutional teaching awards, including the 2025 Ellen Gregg Ingalls/UAB National Alumni Society Award for Lifetime Achievement in Teaching. In 2020, she was honored with the American Society of Nephrology (ASN), Robert G. Narins Lifetime Teaching Award in Education. In 2023, she was awarded the Vicenza International Critical Care Nephrology Award. Her research interests include acute kidney injury, ICU nephrology, and CRRT, with a focus on citrate anticoagulation. She holds the patent for 0.5% Citrate solution for CRRT which is available worldwide as Regiocit or Prismocitrate 18/0.

18th September 2026 Friday

Time Session
08:00
10:00
101
10:30
12:30
13:30
15:30
101

19th September 2026 Saturday

Time Session
07:30
08:15
201BC
14:00
15:30